Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1129-1133

  Veldhuis, Johannes D ^a   Zhang, George ^a   Garmey, James C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN; ANDROSTENEDIONE; CYTOCHROME P450 17; INSULIN; LUTEINIZING HORMONE; MESSENGER RNA; NUCLEAR RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIAZOLE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; STEROIDOGENESIS; THECA CELL;

ANIMALIA; SUIDAE;

EID: 0036962952     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8308     Document Type: Article

References (29)

1. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
2. Marshall JC, Eagleson CA 1999 Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:295-324
3. Yen SS 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12:177-207
4. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
5. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G 1999 Ovulatory and metabolic effects of D-chiroinositol in the polycystic ovary syndrome. N Engl J Med 340:1314-1320
6. Ciotta L, De Leo V, Galvani F, La Marca A, Cianci A 1999 Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. Hum Reprod 14:2951-2958
7. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackgard WG 1989 Suppression of seerum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032
8. Zhang G, Garmey JC, Veldhuis JD 2000 Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17α-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology 141:2735-2742
9. Nestler JE, Jakubowicz DJ, Iuorno MJ 2000 Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. J Pediatr Endocrinol Metab 13:1295-1298
10. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
11. Romero G, Garmey JC, Veldhuis JD 1993 The involvement of inositol phosphoglycan mediators in the modulation of steroidogenesis by insulin and insulin-like growth factor-I. Endocrinology 132:1561-1568
12. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN 2001 Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86:1626-1632
13. Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116
14. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
15. Gasic S, Bodenburg Y, Nagamani M, Green A, Urban RJ 1998 Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 139:4962-4966
16. Lambe KG, Tugwood JD 1996 A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239:1-7
17. Conley AJ, Graham-Lorence SE, Kagimoto M, Lorence MC, Murry BA, Oka K, Sanders D, Mason JI 1992 Nucleotide sequence of a cDNA encoding porcine testis 17α-hydroxylase cytochrome P450. Biochim Biophys Acta 1130:75-77
18. Zhang P, Nason TF, Han XG, Hall PF 1992 Gene for 17α-hydroxylase/C (17-20) lyase P-450: complete nucleotide sequence of the porcine gene and 5′ upstream sequence of the rat gene. Biochim Biophys Acta 1131:345-348
19. Chan YL, Gutell R, Noller HF, Wool IG 1984 The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. J Biol Chem 259:224-230
20. Zhang G, Curtiss LK, Wade RL, Dyer CA 1998 An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17 alpha-hydroxylase, C17-20 lyase. J Lipid Res 39:2406-2414
21. Magoffin DA, Erickson GF 1988 Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 122:2345-2347
22. Veldhuis JD, Garmey JC, Urban RJ, Demers LM, Aggarwal BB 1991 Ovarian actions of tumor necrosis factor-alpha (TNF alpha): pleiotropic effects of TNF alpha on differentiated functions of untransformed swine granulosa cells. Endocrinology 129:641-648
23. Singer VL, Jones LJ, Yue ST, Haugland RP 1997 Characterization of PicoGreen reagent and development of a fluorescence- based solution assay for double-stranded DNA quantitation. Anal Biochem 249:228-238
24. Biason-Lauber A, Kempken B, Werder E, Forest MG, Einaudi S, Ranke MB, Matsuo N, Brunelli V, Schonle EJ, Zachmann M 2000 17α-Hydroxylase/17,20-lyase deficiency as a model to study enzymatic activity regulation: role of phosphorylation. J Clin Endocrinol Metab 85:1226-1231
25. Zhang L-H, Rodriguez H, Ohno S, Miller WL 1995 Serine phosphorylation of human P450 c17 increases 17,20-lyase activity: implications for adrenarche and polycystic ovary syndrome. Proc Natl Acad Sci USA 92:10619-10623
26. Schoppee PD, Garmey JC, Veldhuis JD 2001 Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 66:190-198
27. Lohrke B, Viergutz T, Shahi SK, Pohland R, Wollenhaupt K, Goldammer T, Walzel H, Kanitz W 1998 Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor γ in lutein cells. J Endocrinol 159:429-439
28. Loi CM, Alvey CW, Vassos AB, Randinitis EJ, Sedman AJ, Koup JR 1999 Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolites. J Clin Pharmacol 39:920-926
29. Arlt W, Auchus RJ, Miller WL 2001 Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase. J Biol Chem 276:16767-16771